The Trump Administration has halted an award worth $766 million that was intended to support Moderna in the development of a bird flu vaccine.
The decision to stop the funding is a significant setback for Moderna’s efforts to create a vaccine for the bird flu, and the company has acknowledged the termination of the award.
The award, which was valued at $766 million, was initially intended to aid Moderna in its research and development of a bird flu vaccine, but the Trump Administration has now decided to withdraw the funding, effectively ending the company’s access to these resources.
On Wednesday, End Point News reported that the Trump Administration has terminated a contract worth $766 million with Moderna to develop a bird flu vaccine, with the Department of Health and Human Services (“HHS”) citing that continued investment in the vaccine was not scientifically or ethically justifiable.
Moderna had received an initial award of $176 million in July 2024, which was later expanded to include an additional $590 million in January, and the company had expected to advance the programme into late-stage development with the assistance of the government.
The termination of the contract adds uncertainty to the vaccine’s future, according to Moderna CEO Stéphane Bancel, who stated that the company will explore alternative paths forward for the programme.
The decision is part of a shift in the Trump Administration’s approach to vaccines, which has changed since the days of Operation Warp Speed, when the administration worked closely with drug makers, including Moderna, to speed the development of mRNA-based “vaccines” for covid.
HHS Secretary Robert F. Kennedy Jr., a long-time vaccine sceptic, has cut vaccine contracts and research, and has upset covid-specific guidance, including rescinding existing covid injection recommendations for healthy children and pregnant women.
The Administration’s reconsideration of the bird flu investment comes as two other Moderna products are under review at the FDA, including the company’s next-generation covid “vaccine” and its RSV vaccine, which is being considered for expansion to include high-risk younger adults.
Source: https://expose-news.com/2025/05/30/us-gov-cancels-funding-to-moderna/
Bitchute: https://www.bi,tchut,e.com/channel/YBM3rvf5ydDM/
Telegram: https://t.me/Hopegirl587
EMF Protection Products: www.ftwproject.com
QEG Clean Energy Academy: www.cleanenergyacademy.com
Forbidden Tech Book: www.forbiddentech.website
